This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cystoid Macular Edema
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Prospective, randomized, double-masked, placebo-controlled clinical study to define the effective use of a topical non-steroidal anti-inflammatory drug added to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic cystoid macular edema.

Provided treatments

  • Drug: Nepafenac 0.3%
  • Drug: Saline Solution

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03025945. The sponsor of the trial is Intuor Technologies, Inc. and it is looking for 662 volunteers for the current phase.
Official trial title:
Pseudophakic Cystoid Macular Edema Prevention and Risk Factors; Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo